GYRE THERAPEUTICS, INC. ($GYRE)
Filing Information
| Accession Number | 0001140361-26-025208 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 15, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
8,400
Total Value
$19,376.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jun 11, 2026 | Exercise/Conversion | 2,800 | $0.75 | $2,100.00 | 702,800 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jun 11, 2026 | Sale | 2,800 | $6.17 | $17,276.00 | 700,000 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Exercise/Conversion | 2,800 | $0.00 | $0.00 | 838,701 | Direct | โ | View Details |